Search Results - "Wu, Guang-Jer"

METCAM/MUC18 Plays a Tumor Suppressor Role in the Development of Nasopharyngeal Carcinoma Type I.

Authors: Liu, Yen-Chun Chen, Yu-Jen Wu, Guang-Jer

Source: International Journal of Molecular Sciences. Nov2022, Vol. 23 Issue 21, p13389. 17p.

METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay.

Authors: Pong, Yuan-Hung Su, Yann-Rong Lo, Hsing-Wen et al.

Source: Cancer Biomarkers. 2020, Vol. 27 Issue 3, p377-387. 11p.

METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells.

Authors: Guang-Jer Wu Guo-fang Zeng Wu, Guang-Jer et al.

Source: BMC Cancer. 2/22/2016, Vol. 16, p1-15. 15p. 2 Diagrams, 4 Graphs.

METCAM/MUC18 Decreases the Malignant Propensity of Human Ovarian Carcinoma Cells.

Authors: Wu, Guang-Jer^1,2 guangj.wu@gmail.com

Source: International Journal of Molecular Sciences. Oct2018, Vol. 19 Issue 10, p2976. 1p. 2 Diagrams.

Validating METCAM/MUC18 as a Novel Biomarker to Predict the Malignant Potential of Prostate Cancer at an Early Stage by Using a Modified Gold Nanoparticles-Based Lateral Flow Immunoassay.

Authors: Wu, Jui-Chuang Chuang, Yin-Huan Wei, Yu-Chun et al.

Source: Diagnostics (2075-4418). Mar2021, Vol. 11 Issue 3, p443. 1p.